Stocks and InvestingStocks and Investing
Tue, February 9, 2021
Mon, February 8, 2021
Sat, February 6, 2021
Fri, February 5, 2021

Catherine Schulte Maintained (TWST) at Buy with Increased Target to $200 on, Feb 5th, 2021


Published on 2024-10-27 15:31:21 - WOPRAI, Catherine Schulte
  Print publication without navigation


Catherine Schulte of Baird, Maintained "Twist Bioscience Corporation" (TWST) at Buy with Increased Target from $125 to $200 on, Feb 5th, 2021.

Catherine has made no other calls on TWST in the last 4 months.



There are 2 other peers that have a rating on TWST. Out of the 2 peers that are also analyzing TWST, all agree with Catherine's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Vijay Kumar of "Evercore ISI Group" Downgraded from Buy to Hold and Increased Target to $140 on, Monday, January 4th, 2021
  • Puneet Souda of "SVB Leerink" Maintained at Hold with Increased Target to $100 on, Tuesday, November 24th, 2020